CLYM
Climb Bio Inc.

306
Mkt Cap
$287.74M
Volume
693,907.00
52W High
$5.19
52W Low
$1.05
PE Ratio
-5.62
CLYM Fundamentals
Price
$4.22
Prev Close
$3.77
Open
$3.87
50D MA
$3.00
Beta
0.96
Avg. Volume
2.44M
EPS (Annual)
-$1.53
P/B
1.63
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Climb Bio, Inc. (NASDAQ:CLYM) Short Interest Update
Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,816,835 shares, a decline of...
MarketBeat·16h ago
News Placeholder
More News
News Placeholder
Climb Bio (NASDAQ:CLYM) Director Purchases $24,888.50 in Stock
Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) Director Ra Capital Management, L.P. bought 7,111 shares of the business's stock in a transaction that occurred on Monday, January 5th. The shares were...
MarketBeat·12d ago
News Placeholder
HC Wainwright Reduces Earnings Estimates for Climb Bio
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - HC Wainwright dropped their FY2025 earnings per share (EPS) estimates for Climb Bio in a research report issued to clients and investors on Thursday...
MarketBeat·29d ago
News Placeholder
Climb Bio, Inc. (NASDAQ:CLYM) Receives Consensus Recommendation of "Buy" from Brokerages
Shares of Climb Bio, Inc. (NASDAQ:CLYM - Get Free Report) have been given a consensus rating of "Buy" by the nine brokerages that are covering the firm, MarketBeat.com reports. One research analyst...
MarketBeat·2mo ago
News Placeholder
Brokers Offer Predictions for Climb Bio FY2027 Earnings
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Stock analysts at William Blair reduced their FY2027 earnings per share (EPS) estimates for Climb Bio in a report issued on Monday, November 10th...
MarketBeat·2mo ago
News Placeholder
Nan Fung Trinity HK Ltd. Buys Shares of 463,654 Climb Bio, Inc. $CLYM
Nan Fung Trinity HK Ltd. purchased a new position in Climb Bio, Inc. (NASDAQ:CLYM - Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange...
MarketBeat·2mo ago
News Placeholder
Q1 Earnings Forecast for Climb Bio Issued By William Blair
Climb Bio, Inc. (NASDAQ:CLYM - Free Report) - Investment analysts at William Blair issued their Q1 2026 earnings per share (EPS) estimates for shares of Climb Bio in a report issued on Thursday...
MarketBeat·2mo ago
News Placeholder
Climb Bio (NASDAQ:CLYM) Releases Earnings Results, Misses Estimates By $0.03 EPS
Climb Bio (NASDAQ:CLYM - Get Free Report) issued its quarterly earnings results on Thursday. The company reported ($0.19) earnings per share for the quarter, missing analysts' consensus estimates of...
MarketBeat·2mo ago
News Placeholder
Is Climb Bio, Inc. (CLYM) Stock Outpacing Its Medical Peers This Year?
Here is how Climb Bio, Inc. (CLYM) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year.
Zacks·4mo ago
News Placeholder
Climb Bio, Inc. (CLYM)'s Technical Outlook is Bright After Key Golden Cross
Should investors be excited or worried when a stock's 50-day simple moving average crosses above the 200-day simple moving average?
Zacks·5mo ago
<
1
2
...
>

Latest CLYM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.